Preprint · OA
via OpenAlex
Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells
Diana Clavellina, Wayne Balkan, Joshua M. Hare
Expert Opinion on Biological Therapy · 2023 · ▲ 40 citations
Abstract
INTRODUCTION: Acute myocardial infarction (AMI) remains a leading cause of death in the United States. The limited capacity of cardiomyocytes to regenerate and the restricted contractility of scar tissue after AMI are not addressed by current pharmacologic interventions. Mesenchymal stem/stromal cells (MSCs) have emerged as a promising therapeutic approach due to their low antigenicity, ease of harvesting, and efficacy and safety in preclinical and clinical studies, despite their low survival and engraftment rates. Other stem cell types, such as induced pluripotent stem cells (iPSCs) also show promise, and optimizing cardiac repair requires integrating emerging technologies and strategies. AREAS COVERED: This review offers insights into advancing cell-based therapies for AMI, emphasizing meticulously planned trials with a standardized definition of AMI, for a bench-to-bedside approach. We critically evaluate fundamental studies and clinical trials to provide a comprehensive overview of the advances, limitations and prospects for cell-based therapy in AMI. EXPERT OPINION: MSCs continue to show potential promise for treating AMI and its sequelae, but addressing their low survival and engraftment rates is crucial for clinical success. Integrating emerging technologies such as pluripotent stem cells and conducting well-designed trials will harness the full potential of cell-based therapy in AMI management. Collaborative efforts are vital to developing effective stem cell therapies for AMI patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1080/14712598.2023.2245329
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Clavellina, D., Balkan, W., & Hare, J.M. (2023). Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells. <em>Expert Opinion on Biological Therapy</em>. https://doi.org/10.1080/14712598.2023.2245329
Vancouver
Clavellina D, Balkan W, Hare JM. Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells. Expert Opinion on Biological Therapy. 2023. doi:10.1080/14712598.2023.2245329.
BibTeX
@unpublished{diana2023Stemce,
title = {Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells},
author = {Diana Clavellina and Wayne Balkan and Joshua M. Hare},
journal = {Expert Opinion on Biological Therapy},
year = {2023},
doi = {10.1080/14712598.2023.2245329},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Molecular Medicine 2023
Citation only
Potential role of mesenchymal stem cells in T cell aging
Circulation Research 2011
Open access · OA
Mesenchymal Stem Cells: Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease
Journal of Cellular and Molecular Medicine 2009
Open access · OA
Mesenchymal stem cell‐based therapy: a new paradigm in regenerative medicine
Stem Cell Research & Therapy 2025
Open access · CC-BY
Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases
Elsevier eBooks 2009
Citation only
Mesenchymal Stem Cells
Biomedicines 2022
Open access · CC-BY